Insiders · Profile

Hoberman Kenneth

Director at Nuvectis Pharma. Filing since 12 May 2022. CIK 0001573722

Company

Date

Role

Action

Shares

Amount

Of holding

NVCT Nuvectis Pharma, Inc.

12 May 2022

Director

Bought

6,000

$104.40K

12.2%

1 decision on file.